Literature DB >> 3685995

Parathyroid hormone-related protein of malignancy: active synthetic fragments.

B E Kemp1, J M Moseley, C P Rodda, P R Ebeling, R E Wettenhall, D Stapleton, H Diefenbach-Jagger, F Ure, V P Michelangeli, H A Simmons.   

Abstract

Peptides corresponding to the amino-terminal region of the parathyroid hormone-related protein (PTHrP) of humoral hypercalcemia of malignancy were synthesized. A 34-amino acid peptide, PTHrP(1-34), was two to four times more potent than bovine or human PTH(1-34) in bioassays promoting the formation of adenosine 3',5'-monophosphate (cAMP) and plasminogen activator activity in osteogenic sarcoma cells and adenylate cyclase activity in chick kidney membranes. Like parathyroid hormone itself, in which the activity resides in the first 34 residues, PTHrP peptides of less than 30 residues from the amino terminus showed substantially reduced activity. PTHrP(1-34) had only 6% of the potency of bovine PTH(1-34) in promoting bone resorption in vitro. PTHrP(1-34) strongly promoted the excretion of cAMP and phosphorus and reduced the excretion of calcium in the isolated, perfused rat kidney consistent with the symptoms seen in malignant hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3685995     DOI: 10.1126/science.3685995

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  47 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Endocrine paraneoplastic syndromes with special reference to the elderly.

Authors:  L Bollanti; G Riondino; F Strollo
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

3.  Prediction of the tertiary structure of parathyroid-hormone-related protein (residues 1-34) by the island model.

Authors:  M Ota; N Saitô
Journal:  J Protein Chem       Date:  1992-12

Review 4.  Incidence and pathophysiology of hypercalcemia.

Authors:  G R Mundy
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

5.  Comparison of the effects of amino-terminal synthetic parathyroid hormone-related peptide (PTHrP) of malignancy and parathyroid hormone on resorption of cultured fetal rat long bones.

Authors:  L G Raisz; H A Simmons; S J Vargas; B E Kemp; T J Martin
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

6.  A N-terminal PTHrP peptide fragment void of a PTH/PTHrP-receptor binding domain activates cardiac ET(A) receptors.

Authors:  K D Schlüter; C Katzer; H M Piper
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  High levels of a parathyroid hormone-like protein in milk.

Authors:  A A Budayr; B P Halloran; J C King; D Diep; R A Nissenson; G J Strewler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Age-related decrease in the effect of parathyroid hormone-related protein on cytosolic free calcium level and tension in rat aortic smooth muscle.

Authors:  M Ishikawa; Y Ouchi; M Akishita; K Kozaki; K Toba; A Namiki; T Yamaguchi; H Ito; H Orimo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

Review 9.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

Review 10.  Hypercalcemia in malignancy.

Authors:  G J Strewler; R A Nissenson
Journal:  West J Med       Date:  1990-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.